The National Cannabis Industry Association (NCIA) says the Federal Drug Administration (FDA) should take immediate steps to approve non-psychoactive cannabidiol components such as CBD for general use.
North Carolina House Bill 934, which passed unanimously 114-0, was sent to the State Senate where it currently is in committee.
The U.S. Food and Drug Administration approved 481 drug products in May, according to an online list the agency updated this week.
When the FDA made the announcement, it said it would open past records within weeks. So why did the FDA have such a policy and why was it secret?
North Carolina passed a Right to Try law back in 2015 yet a bill introduced in April could expand that stem cell treatment law.
The Food and Drug Administration this week updated its list of which drugs are in short supply in the nation and which previous drug shortages have been resolved.
WASHINGTON -- The New York Times recently published a lengthy story about stem cell treatments, describing the Food and Drug Administration’s approach as industry friendly.
Illinois’ Cook County is the U.S. jurisdiction most at risk of a measles outbreak this year, according to a study published this month in the British medical journal The Lancet Infectious Diseases.
Seven former Food and Drug Administration commissioners suggested in a couple of articles that the FDA should become an independent agency
Two papers written by seven former FDA commissioners suggest the organization should become an independent agency.
The number of U.S. measles cases confirmed this year reached 839 as of May 10, the highest level for any year since the nation declared the disease eliminated in 2000, according to the Centers for Disease Control and Prevention.
Citizensʼ Council for Health Freedom Media president Twila Brase says the current FDA drug approval process is too long and expensive.
Congress should work on legislation allowing the FDA to fast-track the approval of some drugs already on the market in other developed countries, according to one researcher attached to a west coast free market think tank.
David Gortler, a professor of pharmacology and a former FDA official, says the FDA needs to do more to ensure the quality of drugs delivered to the U.S. market, with particular concern given to generic drugs produced in “sweatshop” countries.
Terminally and chronically ill patients should not be charged for “right to try” treatments, a health-care policy adviser for an Illinois-based free-market think tank, speaking as “a health-care consumer,” said during a recent interview.
As the matter of prescription drug prices continues to generate debate, and some federal government action, one consumer advocate is warning the Food and Drug Administration (FDA) has loosened rules over interactions between physicians and pharmaceutical companies.
The U.S. Food and Drug Administration approved 438 drug products in April, according to an online list the agency updated this week.
Whistleblowers are claiming that pharmaceutical companies are bribing doctors to sell their drugs so they can raise the prices on them.
Legislation that would allow terminally ill patients to access stem cell treatments not yet signed off by the U.S. Food and Drug Administration now is in the North Carolina state Senate after unanimously passing the House last week.
The Food and Drug Administration this week updated its list of which drugs are in short supply in the nation and which previous drug shortages have been resolved.